145 related articles for article (PubMed ID: 36731609)
1. Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement.
Chen Z; Zhu Z; Liang W; Luo Z; Hu J; Feng J; Zhang Z; Luo Q; Yang H; Ding G
Kidney Int; 2023 Apr; 103(4):735-748. PubMed ID: 36731609
[TBL] [Abstract][Full Text] [Related]
2. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
3. Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism.
Luo Q; Liang W; Zhang Z; Zhu Z; Chen Z; Hu J; Yang K; Chi Q; Ding G
Metabolism; 2022 Sep; 134():155245. PubMed ID: 35780908
[TBL] [Abstract][Full Text] [Related]
4. Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation.
Yuan Q; Miao J; Yang Q; Fang L; Fang Y; Ding H; Zhou Y; Jiang L; Dai C; Zen K; Sun Q; Yang J
Cell Death Dis; 2020 May; 11(5):355. PubMed ID: 32393782
[TBL] [Abstract][Full Text] [Related]
5. Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin.
Alquraishi M; Chahed S; Alani D; Puckett DL; Dowker PD; Hubbard K; Zhao Y; Kim JY; Nodit L; Fatima H; Donohoe D; Voy B; Chowanadisai W; Bettaieb A
Cell Commun Signal; 2022 May; 20(1):76. PubMed ID: 35637461
[TBL] [Abstract][Full Text] [Related]
6. FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.
Li SY; Chu PH; Huang PH; Hsieh TH; Susztak K; Tarng DC
Sci Rep; 2019 Apr; 9(1):6693. PubMed ID: 31040292
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
[TBL] [Abstract][Full Text] [Related]
8. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
[TBL] [Abstract][Full Text] [Related]
9. Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes.
Yang Q; Hu J; Yang Y; Chen Z; Feng J; Zhu Z; Wang H; Yang D; Liang W; Ding G
Theranostics; 2020; 10(16):7465-7479. PubMed ID: 32642006
[TBL] [Abstract][Full Text] [Related]
10. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
11. Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy.
Fu J; Shinjo T; Li Q; St-Louis R; Park K; Yu MG; Yokomizo H; Simao F; Huang Q; Wu IH; King GL
JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35133981
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system within the diabetic podocyte.
Márquez E; Riera M; Pascual J; Soler MJ
Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
14. Calpastatin prevents Angiotensin II-mediated podocyte injury through maintenance of autophagy.
Bensaada I; Robin B; Perez J; Salemkour Y; Chipont A; Camus M; Lemoine M; Guyonnet L; Lazareth H; Letavernier E; Hénique C; Tharaux PL; Lenoir O
Kidney Int; 2021 Jul; 100(1):90-106. PubMed ID: 33675847
[TBL] [Abstract][Full Text] [Related]
15. PFKFB3 downregulation aggravates Angiotensin II-induced podocyte detachment.
Huang X; Chen Z; Luo Z; Hao Y; Feng J; Zhu Z; Yang X; Zhang Z; Hu J; Liang W; Ding G
Ren Fail; 2023 Dec; 45(1):2230318. PubMed ID: 37427767
[TBL] [Abstract][Full Text] [Related]
16. Activation of a local renin angiotensin system in podocytes by glucose.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes.
Campbell KN; Raij L; Mundel P
Curr Diabetes Rev; 2011 Jan; 7(1):3-7. PubMed ID: 21067505
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis.
Hsu HH; Hoffmann S; Di Marco GS; Endlich N; Peter-Katalinić J; Weide T; Pavenstädt H
Kidney Int; 2011 Nov; 80(9):959-969. PubMed ID: 21814176
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of podocyte FAK protects against proteinuria and foot process effacement.
Ma H; Togawa A; Soda K; Zhang J; Lee S; Ma M; Yu Z; Ardito T; Czyzyk J; Diggs L; Joly D; Hatakeyama S; Kawahara E; Holzman L; Guan JL; Ishibe S
J Am Soc Nephrol; 2010 Jul; 21(7):1145-56. PubMed ID: 20522532
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II induces podocyte metabolic reprogramming from glycolysis to glycerol-3-phosphate biosynthesis.
Luo Z; Chen Z; Zhu Z; Hao Y; Feng J; Luo Q; Zhang Z; Yang X; Hu J; Liang W; Ding G
Cell Signal; 2022 Nov; 99():110443. PubMed ID: 35988808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
